Graphic health warnings plus pharmacist counseling to help people quit smoking
Official title: Health Warnings and Counseling at Primary Health Care Centers for Smoking Cessation and NCD Prevention: A Randomized Controlled Trial in Bangladesh and Pakistan
Run by Hitotsubashi University · NCT07098065 · Data updated 2026-11-12
This project will test whether combining graphic health warnings with pharmacist-led counseling helps adult smokers in Bangladesh and Pakistan quit.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 90 Years |
| Sex | All |
| Enrollment | 3400 (estimated) |
| Sponsor | Hitotsubashi University Academic / other |
| Locations | 1 site (Dhaka) |
| Status | Recruiting |
| Started | February 1, 2026 |
| Main results expected | February 28, 2027 |
| Study ends | April 30, 2027 |
| Registry record updated | April 14, 2026 |
| Trial ID | NCT07098065 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults (≥18 years) who currently smoke, regularly visit participating pharmacies, can operate a smartphone or tablet, and live in the study area.
✕Probably not a fit
People who are pregnant or lactating, have severe cognitive/psychiatric or medical conditions, do not visit the participating pharmacies, or cannot use a mobile phone are unlikely to be eligible or benefit from this intervention.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a cluster randomized trial enrolling adult smokers through community pharmacies in Bangladesh (about 3,240 participants) and a smaller feasibility sample in Pakistan (~160 participants). Pharmacies are randomized to provide graphic health warnings alone, graphic health warnings plus personalized pharmacist-led counseling, or routine pharmacy services with no additional intervention. The trial will measure smoking cessation outcomes and collect data to model cost-effectiveness and implementation feasibility in primary-care pharmacy settings. Participants must be adult regular pharmacy visitors, able to use a mobile phone or tablet, and be permanent residents of the study area.
Why it matters
Potential benefit: If successful, this approach could raise quit rates by combining motivating graphic warnings with accessible, personalized counseling at community pharmacies.
How similar studies have gone: Graphic health warnings and pharmacist counseling have each shown positive effects on quitting in prior research, but combining them in a cluster RCT at community pharmacies is a relatively novel approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adults aged 18 and older * Adults (≥18 years) who are current smokers (daily or occasional) and regular visitors to participating pharmacies. * Permanent resident of the study area, * Access to mobile phone * Able to operate smartphone or tablet. Exclusion Criteria: * Without pregnancy and lactation * Without cognitive or psychiatric conditions, * Without severe medical conditions, * Participation in other studies, and inability to consent.
Where it's running
-
Global Public Health Research Foundation
Dhaka, Bangladesh Recruiting
Study contacts
- Principal investigator: Md. Mizanur Rahman — Hitotsubashi University
- Study coordinator: Md. Mizanur Rahman, PhD
- Email: mizanurrub78@gmail.com
- Phone: +818035463610
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Using low-dose aspirin after preeclampsia to improve recovery
This study is testing if taking low-dose aspirin for six months after having preeclampsia can help new moms recover better by improving their blood pressure and blood vessel function.
-
IMB-guided health education to boost medication taking and blood pressure control in adults with hypertension
This study tests a health-literacy program based on Information-Motivation-Behavioral Skills to help adults with hypertension who don’t take their medicines regularly to take them more consistently and better control their blood pressure.
-
Renal Nerve Stimulation to Help Blood Pressure in AF and HFpEF
This study tests whether stimulating the kidneys with a catheter can safely lower blood pressure in adults with atrial fibrillation and HFpEF who also have hypertension.
-
Hypertension: Does Education Help Patients Manage Blood Pressure Better?
This study tests whether structured patient education improves blood pressure control and self-management in adults with hypertension who speak Turkish.
-
High BMI and periodontitis in Thai adults under 60
This study tests how common high BMI and periodontitis are among Thai adults aged 18–59 and what factors are linked to them.
-
Long-term GW906 treatment for people with essential hypertension
This trial tests whether long-term GW906 injections are safe and effective for adults with essential hypertension who completed an earlier GW906 study.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.